Clinicopathologic analysis of ampullary neoplasms in 450 patients: Implications for surgical strategy and long-term prognosis

Journal of Gastrointestinal Surgery

Volumn 14, Issue 2, 2010, Pages 379-387

  Winter, Jordan M ^a   Cameron, John L ^a   Olino, Kelly ^a   Herman, Joseph M ^a   de Jong, Mechteld C ^a   Hruban, Ralph H ^a   Wolfgang, Christopher L ^a   Eckhauser, Frederic ^a   Edil, Barish H ^a   Choti, Michael A ^a   Schulick, Richard D ^a   Pawlik, Timothy M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Ampullary adenocarcinoma; Ampullary carcinoma; Ampullary neoplasia; Pancreaticoduodenectomy; Whipple

Indexed keywords

ADENOCARCINOMA; ADENOMA; ADULT; AGED; ARTICLE; BILE DUCT TUMOR; COMPARATIVE STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME; VATER PAPILLA;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; PROGNOSIS; TREATMENT OUTCOME;

EID: 77951284287     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1080-7     Document Type: Article

References (47)

1. Baggenstoss AH. Major duodenal papilla. Variations of pathologic interest and lesions of the mucosa. Arch Path. 1938; 26: 853-868.
2. Neugut AI, Jacobson JS, Rella VA. Prevalence and incidence of colorectal adenomas and cancer in asymptomatic persons. Gastrointest Endosc Clin N Am. 1997; 7(3): 387-399.
3. Benhamiche AM, Jouve JL, Manfredi S et al. Cancer of the ampulla of Vater: results of a 20-year population-based study. Eur J Gastroenterol Hepatol. 2000; 12(1): 75-79.
4. Katsinelos P, Paroutoglou G, Kountouras J et al. Safety and long-term follow-up of endoscopic snare excision of ampullary adenomas. Surg Endosc. 2006; 20(4): 608-613.
5. Catalano MF, Linder JD, Chak A et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc. 2004; 59(2): 225-232.
6. Howe JR, Klimstra DS, Moccia RD et al. Factors predictive of survival in ampullary carcinoma. Ann Surg. 1998; 228(1): 87-94.
7. Talamini MA, Moesinger RC, Pitt HA et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg. 1997; 225(5): 590-599. discussion 99-600.
8. Beghelli S, Orlandini S, Moore PS et al. Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis. Virchows Arch. 2002; 441(1): 19-24.
9. Botsios D, Zacharakis E, Lambrou I et al. Our local experience with the surgical treatment of ampullary cancer. Int Semin Surg Oncol. 2005; 2: 16.
10. Brown KM, Tompkins AJ, Yong S et al. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg. 2005; 140(6): 529-532. discussion 32-33.
11. el-Ghazzawy AG, Wade TP, Virgo KS, Johnson FE. Recent experience with cancer of the ampulla of Vater in a national hospital group. Am Surg. 1995; 61(7): 607-611.
12. Hsu HP, Yang TM, Hsieh YH et al. Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol. 2007; 14(1): 50-60.
13. Di Giorgio A, Alfieri S, Rotondi F et al. Pancreatoduodenectomy for tumors of Vater's ampulla: report on 94 consecutive patients. World J Surg. 2005; 29(4): 513-518.
14. Winter JM, Cameron JL, Campbell KA et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2006; 10(9): 1280-1290. discussion 90.
15. Yeo CJ, Barry MK, Sauter PK et al. Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg. 1993; 218(3): 229-237. discussion 37-38.
16. Cameron JL. Atlas of Surgery: Gallbladder and Biliary Tract, the Liver, Portasystemic Shunts, the Pancreas. Vol. 1: B C Decker Inc, 1990.
17. Yeo CJ, Cameron JL. Alternative techniques for performing the Whipple operation. Adv Surg. 1996; 30: 293-310.
18. Yeo CJ, Cameron JL, Sohn TA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997; 226(3): 248-257. discussion 57-60.
19. Riall TS, Cameron JL, Lillemoe KD et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: update on 5-year survival. J Gastrointest Surg. 2005; 9(9): 1191-1204. discussion 204-206.
20. Yeo CJ, Cameron JL, Lillemoe KD et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000; 232(3): 419-429.
21. Branum GD, Pappas TN, Meyers WC. The management of tumors of the ampulla of Vater by local resection. Ann Surg. 1996; 224(5): 621-627.
22. Halsted W. Contributions to the surgery of the bile passages, especially of the common bile-duct. Boston Medical and Surgical Journal 1899; 141: 645-661.
23. Howard JM. Development and progress in resective surgery for pancreatic cancer. World J Surg. 1999; 23(9): 901-906.
24. Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR. History of the pancreas. Am J Surg. 1983; 146(5): 539-550.
25. Hirschel G. Die Resektion des Duodenums mit der Papille wegen Karzinoms. Münchener medizinische Wochenschrift 1914; 61: 1728.
26. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg. 1935; 102(4): 763.
27. Beger HG, Treitschke F, Gansauge F et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg. 1999; 134(5): 526-532.
28. Rattner DW, Fernandez-del Castillo C, Brugge WR, Warshaw AL. Defining the criteria for local resection of ampullary neoplasms. Arch Surg. 1996; 131(4): 366-371.
29. Monson JR, Donohue JH, McEntee GP et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg. 1991; 126(3): 353-357.
30. Barauskas G, Gulbinas A, Pranys D et al. Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma. J Hepatobiliary Pancreat Surg. 2008; 15(4): 423-428.
31. Yoon YS, Kim SW, Park SJ et al. Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg. 2005; 242(1): 92-100.
32. Fathy O, Abdel-Wahab M, Elghwalby N et al. Surgical management of peri-ampullary tumors: a retrospective study. Hepatogastroenterology 2008; 55(85): 1463-1469.
33. Lagoudianakis EE, Tsekouras D, Koronakis N et al. A prospective comparison of ampullectomy with pancreaticoduodenectomy for the treatment of periampullary cancer. J Buon. 2008; 13(4): 569-572.
34. Qiao QL, Zhao YG, Ye ML et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007; 31(1): 137-143. discussion 44-46.
35. Bottger TC, Boddin J, Heintz A, Junginger T. Clinicopathologic study for the assessment of resection for ampullary carcinoma. World J Surg. 1997; 21(4): 379-383.
36. Demetriades H, Zacharakis E, Kirou I et al. Local excision as a treatment for tumors of ampulla of Vater. World J Surg Oncol. 2006; 4: 14.
37. Nikfarjam M, Muralidharan V, McLean C, Christophi C. Local resection of ampullary adenocarcinomas of the duodenum. ANZ J Surg. 2001; 71(9): 529-533.
38. Dixon E, Vollmer CM Jr., Sahajpal A et al. Transduodenal resection of peri-ampullary lesions. World J Surg. 2005; 29(5): 649-652.
39. Sperti C, Pasquali C, Piccoli A et al. Radical resection for ampullary carcinoma: long-term results. Br J Surg. 1994; 81(5): 668-671.
40. Sosa JA, Bowman HM, Gordon TA et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998; 228(3): 429-438.
41. Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg. 1995; 221(1): 43-49.
42. Winter JM, Cameron JL, Campbell KA, et al. 1423 Pancreaticoduodenectomies for pancreatic cancer: a single institution experience. J Gastrointest Surg. 2006.
43. Toh SK, Davies N, Dolan P et al. Good outcome from surgery for ampullary tumour. Aust N Z J Surg. 1999; 69(3): 195-198.
44. Roder JD, Schneider PM, Stein HJ, Siewert JR. Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg. 1995; 82(12): 1693-1696.
45. Chareton B, Coiffic J, Landen S et al. Diagnosis and therapy for ampullary tumors: 63 cases. World J Surg. 1996; 20(6): 707-712.
46. Yamaguchi K, Enjoji M, Tsuneyoshi M. Pancreatoduodenal carcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9. J Surg Oncol. 1991; 47(3): 148-154.
47. McCarthy DM, Hruban RH, Argani P et al. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases. Mod Pathol. 2003; 16(3): 272-278.